New Feature
  • New: Financial Statement (Balance Sheet, Income Statement & Cash Flow)
  • New: Go to Stock Page (E.g FRONTKN) > Financial Highlights Section
  • New: Financial Statement (Balance Sheet, Income Statement & Cash Flow)
  • New: Go to Stock Page (E.g FRONTKN) > Financial Highlights Section
VIEW SAMPLE
add free Download App
premium Premium Account

Last Price Change Volume
Open: Day Range: Prev Close:


Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

DUOPHARMA BIOTECH BERHAD

Particulars of substantial Securities Holder

Name EMPLOYEES PROVIDENT FUND BOARD
Address 5TH FLOOR, EPF TOWER,
NO.1, PERSIARAN KWASA UTAMA,
Shah Alam
40150 Selangor
Malaysia.
Company No. EPF ACT 1991
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary shares

Details of changes

No Date of change
No of securities
 Type of Transaction Nature of Interest
27 Dec 2022
187,600
 Disposed Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn.Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang,50450 Kuala Lumpur.
Description of "Others" Type of Transaction
27 Dec 2022
68,700
 Acquired Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn.Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang,50450 Kuala Lumpur.
Description of "Others" Type of Transaction
27 Dec 2022
61,000
 Disposed Direct Interest
Name of registered holder Citigroup Nominees (Tempatan) Sdn.Bhd.
Address of registered holder Level 42, Menara Citibank, 165 Jalan Ampang,50450 Kuala Lumpur.
Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred Disposal of 187,600 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board Acquisition of 68,700 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (TEMPLETON) Disposal of 61,000 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (F.TEMISLAMIC) IC
Nature of interest Indirect Interest
Direct (units)
Direct (%)
Indirect/deemed interest (units) 95,815,567
Indirect/deemed interest (%) 10.062
Total no of securities after change 95,815,567
Date of notice 28 Dec 2022
Date notice received by Listed Issuer 30 Dec 2022


Remarks :
Total number of Duopharma Biotech Berhad shares held are as follows:

(a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD: 80,050,877

(b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (AM INV): 3,204,000

(c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD (ARIM): 811,162

(d) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(TEMPLETON): 3,908,900

(e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(ASIANISLAMIC) IC: 67,596

(f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(F.TEMISLAMIC) IC: 1,567,600

(g) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(CPIAM EQ) IC: 1,849,600

(h) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(NIAM EQ) IC: 1,975,233

(i) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD.
EMPLOYEES PROVIDENT FUND BOARD(CGS CIMB-SBL): 2,380,599

Announcement Info

Company Name DUOPHARMA BIOTECH BERHAD
Stock Name DPHARMA
Date Announced 30 Dec 2022
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-30122022-00036




Close